Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Callion Pharma is a specialized pharmaceutical company focused on developing and commercializing advanced nutritional products for individuals with malabsorption syndromes. The company is best known for its DEKAs brand, which utilizes a clinically validated delivery technology to enhance the absorption of fat-soluble vitamins (A, D, E, and K). These products are specifically formulated for patients with conditions such as cystic fibrosis, cholestatic liver disease, and those who have undergone bariatric surgery. Callion Pharma's mission is to provide high-quality, science-based nutritional solutions that address the unique needs of patient populations with compromised digestive health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DEKAs Pharma.